Clinical Trial Update: NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatitis [NA]

View source ↗

Summary

Clinical trial update examining NAT2 genotyping to guide a re-challenge protocol and isoniazid titration in patients who developed hepatitis from anti-tuberculo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Liver Injury

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatotoxicity | NA | Status: UNKNOWN